102 related articles for article (PubMed ID: 2287561)
1. The time to reach steady state after the administration of intravenous bolus, constant infusion, and oral immediate-release and sustained-release preparations.
Chow MS; Sun H
Pharmacotherapy; 1990; 10(6):400-5. PubMed ID: 2287561
[TBL] [Abstract][Full Text] [Related]
2. A method of determining the in vivo drug release rate constant of sustained-release preparation.
Sun H; Chow MS
Drug Metab Dispos; 1995 Apr; 23(4):449-54. PubMed ID: 7600910
[TBL] [Abstract][Full Text] [Related]
3. Analysis of metabolite formation pharmacokinetics after intravenous and oral administration of the parent drug using inverse Laplace transformation.
Weiss M
Drug Metab Dispos; 1998 Jun; 26(6):562-5. PubMed ID: 9616192
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of oral morphine sulfate in dogs: a comparison of sustained release and conventional formulations.
Dohoo SE; Tasker RA
Can J Vet Res; 1997 Oct; 61(4):251-5. PubMed ID: 9342447
[TBL] [Abstract][Full Text] [Related]
5. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
[TBL] [Abstract][Full Text] [Related]
6. Conversion from intravenous procainamide to oral sustained release tablets in cardiac patients.
Kalin ML; Babich MF; Klinke WP; Hui WK
Can J Cardiol; 1990; 6(1):15-8. PubMed ID: 2310989
[TBL] [Abstract][Full Text] [Related]
7. Influence of administration rate on propofol plasma-effect site equilibration.
Struys MM; Coppens MJ; De Neve N; Mortier EP; Doufas AG; Van Bocxlaer JF; Shafer SL
Anesthesiology; 2007 Sep; 107(3):386-96. PubMed ID: 17721240
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and electrocardiographic effects of a new controlled-release form of flecainide acetate: comparison with the standard form and influence of the CYP2D6 polymorphism.
Tennezé L; Tarral E; Ducloux N; Funck-Brentano C
Clin Pharmacol Ther; 2002 Aug; 72(2):112-22. PubMed ID: 12189358
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of an immediate release, a controlled release and a two pulse dosage form in dogs.
Löbenberg R; Kim JS; Amidon GL
Eur J Pharm Biopharm; 2005 May; 60(1):17-23. PubMed ID: 15848051
[TBL] [Abstract][Full Text] [Related]
10. The kinetics of nifedipine release from porous hydrophilic matrices and the pharmacokinetics in man.
Leucuta SE
Pharmazie; 1988 Dec; 43(12):845-8. PubMed ID: 3247376
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of theophylline in beagle dogs and asthmatic patients after multiple oral doses of sustained-release theophylline tablet formulation.
Nosaka H; Takagi K; Hasegawa T; Ogura Y; Mizukami Y; Satake T
Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):528-35. PubMed ID: 3781672
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of oral sustained release clonidine in humans.
MacGregor TR; Relihan GL; Keirns JJ
Arzneimittelforschung; 1985; 35(1A):440-6. PubMed ID: 4039184
[TBL] [Abstract][Full Text] [Related]
13. Faster clearance of sustained release verapamil in men versus women: continuing observations on sex-specific differences after oral administration of verapamil.
Krecic-Shepard ME; Barnas CR; Slimko J; Schwartz JB
Clin Pharmacol Ther; 2000 Sep; 68(3):286-92. PubMed ID: 11014410
[TBL] [Abstract][Full Text] [Related]
14. The relationships between half-life (t1/2) and mean residence time (MRT) in the two-compartment open body model.
Sobol E; Bialer M
Biopharm Drug Dispos; 2004 May; 25(4):157-62. PubMed ID: 15108218
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of a sustained-release dosage form of clomipramine.
Herrera D; Mayet L; Galindo MC; Jung H
J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1488-93. PubMed ID: 11185671
[TBL] [Abstract][Full Text] [Related]
16. Serum levels and pharmacokinetics of ordinary and sustained-release lithium carbonate in manic patients during chronic dosage.
Thornhill DP
Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):257-61. PubMed ID: 3089950
[TBL] [Abstract][Full Text] [Related]
17. [The pharmacokinetics and bioequivalence of acipimox sustained-release tablets after a single and multiple oral administration in healthy dogs].
Yang XG; Nie SF; Bai HJ; Zhang GJ; Pan WS
Yao Xue Xue Bao; 2005 May; 40(5):457-61. PubMed ID: 16220793
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic/pharmacodynamic (PK/PD) evaluation of a once-daily treatment using ciprofloxacin in an extended-release dosage form.
Schuck EL; Dalhoff A; Stass H; Derendorf H
Infection; 2005 Dec; 33 Suppl 2():22-8. PubMed ID: 16518708
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levels.
van der Vet AP; Drost RH; Kreukniet J; Maes RA
Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):423-9. PubMed ID: 6490224
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of vindesine given as an intravenous bolus and 24-hour infusion in humans.
Ohnuma T; Norton L; Andrejczuk A; Holland JF
Cancer Res; 1985 Jan; 45(1):464-9. PubMed ID: 3965152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
